Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T18:23:08.521Z.
Calculation as of: 2026-10-06T18:23:08.521Z.
Quote observation: 2026-10-06T18:17:06.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ddbbc57cb4d55ad36c9ea810397d6785d98e1ed361c578be0001995c9b2602d4
EARNINGS YIELD
N/A
Market Cap
$8.13M
Earnings Yield
N/A
TTM Avg
1206.46%
3Y Avg
1192.40%
5Y Avg
1192.40%
Market Cap
$7.53M
Earnings Yield
N/A
TTM Avg
179.45%
3Y Avg
179.45%
5Y Avg
179.45%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Traws Pharma, Inc. (TRAW) | $7.94M | N/A | N/A | N/A | N/A |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.95M | N/A | N/A | N/A | N/A |
| Aprea Therapeutics, Inc. (APRE)vs › | $7.95M | N/A | N/A | N/A | N/A |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.76M | N/A | N/A | N/A | N/A |
| GT Biopharma, Inc. (GTBP)vs › | $8.13M | N/A | 1206.46% | 1192.40% | 1192.40% |
| HeartSciences Inc. (HSCS)vs › | $8.23M | N/A | N/A | N/A | N/A |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.64M | N/A | N/A | N/A | N/A |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.33M | N/A | N/A | N/A | N/A |
| Skye Bioscience, Inc. (SKYE)vs › | $7.53M | N/A | 179.45% | 179.45% | 179.45% |
| DataMEDS AI, Inc. (MEDS)vs › | $8.51M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
